WG Hodge, J Lachaine, I Steffensen, C Murray … - British Journal of Ophthalmology, 2008 - bjo.bmj.com Results: Eight unique RCTs evaluating a total of 1,722 individuals were included
in this systematic review. Analysis did not show a significant reduction in the
mean IOP from patients receiving latanoprost compared with those receiving ... Cited by 13 - Related articles - BL Direct - All 4 versions
MN Lazaridou, DMI Montgomery, W Onn Ho, … - Current Medical Research and Opinion®, 2008 - informahealthcare.com Methods: The glaucoma database of the Glasgow Royal Infirmary was reviewed
retrospectively to identify patients ≥ 18 years of age with primary open-angle
glaucoma or ocular hypertension in at least one eye who had been switched ... Cited by 2 - Related articles - All 6 versions
SC Loon, F MMed, G Liew, M MMed, A Fung, … - Clinical & experimental ophthalmology, 2008 - pt.wkhealth.com This paper aims to compare the efficacy and tolerability of timolol versus
brimonidine in the treatment of glaucoma. Comprehensive searches were performed
using Medline, Embase and the Cochrane Controlled Trials Register for ... Cited by 3 - Related articles - BL Direct - All 5 versions
- ►nih.gov [PDF] JD Stein, FA Sloan, PP Lee - American journal of ophthalmology, 2007 - Elsevier To determine rates of glaucoma medication utilization among glaucoma suspects in
the Medicare Current Beneficiary Survey (MCBS) and identify recent utilization
patterns for various hypotensive drug classes. Cited by 3 - Related articles - All 14 versions
[CITATION] Alphagan Rm/Betaxolol Clinical Success Study Group. Comparison of the clinical success and …
SA Osborne, DMI Montgomery, D Morris, IC … - Eye, 2004 - nature.com Aims Since its introduction in 1996, brimonidine tartrate 0.2% ophthalmic
solution (Alphagan, Allergan) twice daily has become established as an effective
intra ocular pressure-lowering treatment. While the efficacy of Alphagan ... Cited by 11 - Related articles - All 3 versions
MS Dirks, RJ Noecker, M Earl, S Roh, SM … - Advances in therapy, 2006 - Springer This multicenter, randomized, double-blind clinical trial was undertaken to com-
pare the intraocular pressure (IOP)-lowering efficacy and safety of topical
bimato- prost 0.03% with that of latanoprost 0.005% for the treatment of ... Cited by 14 - Related articles - BL Direct - All 3 versions
N Kitnarong, Y Zhao, PA Netland, AR Kent - Advances in therapy, 2004 - Springer The purpose of this study was to assess the efficacy of latanoprost 0.005% and
tim- olol maleate 0.5% in black and white patients with elevated intraocular
pressure (IOP). This double-masked, randomized, 2-period crossover study ... Cited by 6 - Related articles - BL Direct - All 3 versions
P Denis, A Lafuma, B Khoshnood, V Mimaud, … - Current Medical Research and Opinion®, 2007 - informahealthcare.com Ph. denisa, A. lafumab, b. Khoshnoodc, V. Mimaudb and G. berdeauxc,d ...
Address for correspondence: Gilles Berdeaux, MD, Alcon France, 4, rue Henri
Sainte‑Claire Deville, F‑92563 Rueil‑Malmaison Cedex, France. Tel.: ... Cited by 19 - Related articles - BL Direct - All 5 versions
- ►nih.gov FA Knox, M Barry, B McGowan, CO'Brien - British journal of ophthalmology, 2006 - bjo.bmj.com Methods: A retrospective analysis was performed of drug costs, prescribing data,
and operation rates for glaucoma in Ireland from January 1996 to December 2003.
Information regarding costs and volume were obtained for each type of ... Cited by 10 - Related articles - BL Direct - All 7 versions
